GARUTI, ANNA
 Distribuzione geografica
Continente #
EU - Europa 8.224
AS - Asia 829
NA - Nord America 799
Continente sconosciuto - Info sul continente non disponibili 93
SA - Sud America 82
AF - Africa 16
OC - Oceania 5
Totale 10.048
Nazione #
IT - Italia 8.057
US - Stati Uniti d'America 761
SG - Singapore 307
CN - Cina 210
VN - Vietnam 164
BD - Bangladesh 67
FR - Francia 61
BR - Brasile 49
HK - Hong Kong 28
DE - Germania 25
AR - Argentina 23
CA - Canada 16
FI - Finlandia 14
GB - Regno Unito 13
IQ - Iraq 11
IN - India 10
JP - Giappone 10
ES - Italia 7
NL - Olanda 7
UA - Ucraina 7
CH - Svizzera 6
RU - Federazione Russa 6
EC - Ecuador 5
AU - Australia 4
ID - Indonesia 4
IE - Irlanda 4
MX - Messico 4
SE - Svezia 4
SV - El Salvador 4
ZA - Sudafrica 4
CR - Costa Rica 3
HN - Honduras 3
TR - Turchia 3
UZ - Uzbekistan 3
AL - Albania 2
CO - Colombia 2
JM - Giamaica 2
KE - Kenya 2
MA - Marocco 2
NG - Nigeria 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
RS - Serbia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
JO - Giordania 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
OM - Oman 1
PE - Perù 1
PF - Polinesia Francese 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 9.955
Città #
Genova 4.762
Genoa 2.020
Rapallo 731
Vado Ligure 479
San Jose 180
Ashburn 131
Singapore 130
Lauterbourg 53
Ho Chi Minh City 47
Beijing 46
New York 32
Hanoi 28
Hong Kong 27
Council Bluffs 25
Los Angeles 24
Frankfurt am Main 23
Santa Clara 20
Helsinki 14
Chicago 13
Da Nang 12
Bordighera 11
Haiphong 11
Naples 10
Tokyo 9
Dallas 8
Phoenix 8
Kyiv 6
Orem 6
Zurich 6
Amsterdam 5
Atlanta 5
Biên Hòa 5
Charlotte 5
Milan 5
Buenos Aires 4
Cardiff 4
London 4
Montreal 4
Paris 4
Rome 4
San Francisco 4
Stockholm 4
São Paulo 4
Tianjin 4
Baghdad 3
Birmingham 3
Buffalo 3
Can Tho 3
Detroit 3
Dublin 3
Jacksonville 3
Johannesburg 3
Madrid 3
Mexico City 3
Miami 3
Rio de Janeiro 3
San Salvador 3
Secaucus 3
Sydney 3
Thái Bình 3
Turin 3
Washington 3
Anaheim 2
Ankara 2
Bossier City 2
Boydton 2
Brooklyn 2
Cagliari 2
Catania 2
Chennai 2
Davenport 2
Denver 2
Des Moines 2
Dhaka 2
Draper 2
Erie 2
Guayaquil 2
Hohenwald 2
Houston 2
Hải Dương 2
Iowa City 2
Karbala 2
Lansdowne 2
Memphis 2
Milwaukee 2
Mobile 2
Nairobi 2
Newark 2
Nha Trang 2
Panama City 2
Philadelphia 2
Porto Alegre 2
Prosper 2
Quảng Ngãi 2
Quận Ba 2
Reggio Emilia 2
Rochester 2
San Bernardino 2
San José 2
São Carlos 2
Totale 9.067
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 326
APO866 activity in hematologic malignancies: a preclinical in vitro study. 252
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 252
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 226
Uncovering the genomic heterogeneity of multifocal breast cancer 214
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 212
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 209
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 208
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 206
Ras-induced resistance to lapatinib is overcome by MEK inhibition 205
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 199
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 199
Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages 197
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 196
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 195
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 192
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 191
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 190
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 190
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 189
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 185
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 185
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 181
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 180
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 179
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 179
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 178
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 178
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 177
High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas. 175
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 175
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 173
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 173
Mutant presenilin 1 increases the expression and activity of BACE1. 171
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. 170
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 170
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 167
Catastrophic NAD+ Depletion through Nampt Inhibition in Activated T Lymphocytes Reduces Demyelination and Disability in EAE. 167
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 164
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 159
Germline mutations in the von Hippel-Lindau gene in Italian patients. 158
Optimization of a wga-free molecular tagging-based ngs protocol for ctcs mutational profiling 158
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 156
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 154
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 154
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 153
Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples. 141
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 138
Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer 138
Depletion of the intracellular coenzyme NAD plus in activated T-cells ameliorates experimental autoimmune encephalomyelitis 130
The role of alpha-interferon in chronic myelogenous leukaemia in imatinib era. 124
Mutational analysis of BRCA1 and BRCA2 genes in high grade serous ovarian carcinoma with Next Generation Sequencing (NGS); correlation between somatic and germline mutations 124
Transcriptome Sequencing Of The Transition From Normal Epithelium To Invasive Cancer Reveals Insights Into The Carcinogenesis Of Hpv+ And Hpv- Vulvar Neoplasia 123
Potent Synergistic Activity of the NAD plus Synthesis Inhibitor APO866 and of the Apoptosis Inducer TRAIL in in Vitro and Ex Vivo Cellular Models of Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. 116
β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. 104
SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer 93
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer 84
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 66
Totale 10.048
Categoria #
all - tutte 30.817
article - articoli 29.598
book - libri 0
conference - conferenze 832
curatela - curatele 0
other - altro 387
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022789 28 59 66 110 28 50 52 168 34 63 46 85
2022/2023896 93 98 10 100 147 121 10 64 133 1 112 7
2023/2024487 20 53 4 69 33 98 19 38 19 18 37 79
2024/20251.307 47 85 43 90 151 110 116 278 37 51 137 162
2025/20262.316 297 63 118 159 354 164 344 118 181 238 146 134
2026/2027201 201 0 0 0 0 0 0 0 0 0 0 0
Totale 10.048